Page last updated: 2024-10-23

betaxolol and Retinal Diseases

betaxolol has been researched along with Retinal Diseases in 3 studies

Retinal Diseases: Diseases involving the RETINA.

Research Excerpts

ExcerptRelevanceReference
"Betaxolol is a beta(1)-adrenergic blocker but its neuroprotective action is generally thought to be due to its calcium channel blocking properties."1.30Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. ( Bae, JH; Chidlow, G; DeSantis, L; Nash, MS; Osborne, NN; Ugarte, M; Wood, JP, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fletcher, EL1
Cheon, EW1
Park, CH1
Kim, YS1
Cho, CH1
Chung, YC1
Kwon, JG1
Yoo, JM1
Choi, WS1
Cho, GJ1
Osborne, NN1
DeSantis, L1
Bae, JH1
Ugarte, M1
Wood, JP1
Nash, MS1
Chidlow, G1

Other Studies

3 other studies available for betaxolol and Retinal Diseases

ArticleYear
Understanding neurochemical changes during retinal diseases.
    Clinical & experimental ophthalmology, 2004, Volume: 32, Issue:5

    Topics: Animals; Betaxolol; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; N-Methylaspartate; Neur

2004
Protective effects of betaxolol in eyes with kainic acid-induced neuronal death.
    Brain research, 2006, Jan-19, Volume: 1069, Issue:1

    Topics: Analysis of Variance; Animals; Betaxolol; Cell Count; Cell Death; Choline O-Acetyltransferase; Disea

2006
Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina.
    Experimental eye research, 1999, Volume: 69, Issue:3

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium Channel Blockers;

1999